Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 50012516
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119826(5-(6-Amino-purin-9-yl)-pentanoic acid hydroxyamide...)
Affinity DataIC50: 7.60E+3nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119832(4-(6-Amino-purin-9-yl)-N-hydroxy-butyramide | CHEM...)
Affinity DataIC50: 7.90E+3nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119858(2-[(S)-3-((S)-6-Amino-purin-9-yl)-cyclopentyloxy]-...)
Affinity DataIC50: 1.08E+4nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119858(2-[(S)-3-((S)-6-Amino-purin-9-yl)-cyclopentyloxy]-...)
Affinity DataIC50: 1.08E+4nMAssay Description:Inhibitory concentration against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119855(2-{[(1S,4R)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50: 1.36E+4nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119855(2-{[(1S,4R)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50: 1.36E+4nMAssay Description:Inhibitory concentration against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119842(6-(6-Amino-purin-9-yl)-hexanoic acid hydroxyamide ...)
Affinity DataIC50: 3.54E+4nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119853(2-{[(1S,4S)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50: 7.20E+4nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119860(2-{[(1S,4R)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50: 7.80E+4nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119857([(S)-3-((S)-6-Amino-purin-9-yl)-cyclopentyloxy]-ac...)
Affinity DataIC50: 7.90E+4nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119821(2-[3-(6-Amino-purin-9-yl)-propoxy]-N-hydroxy-aceta...)
Affinity DataIC50: 9.40E+4nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119854(2-{[(1R,4S)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50: 9.60E+4nMAssay Description:Inhibitory concentration against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119861(2-{[(1R,4S)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50: 9.80E+4nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119854(2-{[(1R,4S)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50: 1.02E+5nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119851(2-[(R)-3-((R)-6-Amino-purin-9-yl)-cyclopentyloxy]-...)
Affinity DataIC50: 1.10E+5nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119851(2-[(R)-3-((R)-6-Amino-purin-9-yl)-cyclopentyloxy]-...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibitory concentration against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119856([(R)-3-((R)-6-Amino-purin-9-yl)-cyclopentyloxy]-ac...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119850(2-{[(1R,4R)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119852(2-{[(1S,3S)-3-(6-amino-9H-purin-9-yl)cyclopentyl]o...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119859(2-{[(1R,3R)-3-(6-amino-9H-purin-9-yl)cyclopentyl]o...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed